JP2022028645A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022028645A5 JP2022028645A5 JP2021153771A JP2021153771A JP2022028645A5 JP 2022028645 A5 JP2022028645 A5 JP 2022028645A5 JP 2021153771 A JP2021153771 A JP 2021153771A JP 2021153771 A JP2021153771 A JP 2021153771A JP 2022028645 A5 JP2022028645 A5 JP 2022028645A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- antibody
- binding domain
- antigen binding
- subunit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18214994.8 | 2018-12-21 | ||
| EP18214994 | 2018-12-21 | ||
| JP2021534306A JP7061733B2 (ja) | 2018-12-21 | 2019-12-19 | Ｃｄ３に結合する抗体 |
| PCT/EP2019/086144 WO2020127619A1 (en) | 2018-12-21 | 2019-12-19 | Antibodies binding to cd3 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021534306A Division JP7061733B2 (ja) | 2018-12-21 | 2019-12-19 | Ｃｄ３に結合する抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022028645A JP2022028645A (ja) | 2022-02-16 |
| JP2022028645A5 true JP2022028645A5 (enExample) | 2022-12-27 |
| JP7653881B2 JP7653881B2 (ja) | 2025-03-31 |
Family
ID=78819196
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021126403A Active JP7090780B2 (ja) | 2018-12-21 | 2021-08-02 | Ｃｄ３に結合する抗体 |
| JP2021153771A Active JP7653881B2 (ja) | 2018-12-21 | 2021-09-22 | Ｃｄ３に結合する抗体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021126403A Active JP7090780B2 (ja) | 2018-12-21 | 2021-08-02 | Ｃｄ３に結合する抗体 |
Country Status (1)
| Country | Link |
|---|---|
| JP (2) | JP7090780B2 (enExample) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010095031A2 (en) * | 2009-02-23 | 2010-08-26 | Glenmark Pharmaceuticals S.A. | Humanized antibodies that bind to cd19 and their uses |
| WO2014028748A1 (en) * | 2012-08-15 | 2014-02-20 | Irm Llc | Interleukin 2 antibodies and antibody complexes |
| EA201891502A1 (ru) * | 2013-02-26 | 2018-12-28 | Роше Гликарт Аг | Биспецифические антигенсвязывающие молекулы, активирующие т-клетки |
| KR102411972B1 (ko) * | 2014-08-04 | 2022-06-23 | 에프. 호프만-라 로슈 아게 | 이중특이적 t 세포 활성화 항원 결합 분자 |
| CN107074955B (zh) * | 2014-11-20 | 2021-06-22 | 豪夫迈·罗氏有限公司 | 针对FolR1和CD3的T细胞活化性双特异性抗原结合分子 |
| TWI744242B (zh) * | 2015-07-31 | 2021-11-01 | 德商安美基研究（慕尼黑）公司 | Egfrviii及cd3抗體構築體 |
| CN107949574A (zh) * | 2015-10-02 | 2018-04-20 | 豪夫迈·罗氏有限公司 | 双特异性t细胞活化性抗原结合分子 |
| WO2018060301A1 (en) * | 2016-09-30 | 2018-04-05 | F. Hoffmann-La Roche Ag | Bispecific antibodies against cd3 |
-
2021
- 2021-08-02 JP JP2021126403A patent/JP7090780B2/ja active Active
- 2021-09-22 JP JP2021153771A patent/JP7653881B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019533441A5 (enExample) | ||
| JP2021507698A5 (enExample) | ||
| IL269395B1 (en) | Immunoconjugations of anti–PD–1 antibody with IL–2 or IL–15 mutation | |
| FI3802598T3 (fi) | Dll3/cd3:a sitovia proteiineja syövän hoitamiseksi | |
| FI3177643T5 (fi) | T-soluja aktivoivia bispesifisiä antigeeniä sitovia molekyylejä | |
| JP2019502712A5 (enExample) | ||
| HRP20200306T1 (hr) | Bispecifične molekule vezane na antigene koji aktiviraju t stanice specifične za cd3 i cea | |
| IL272747B2 (en) | Bispecific antibodies 1 + 2 | |
| CN106164095A (zh) | 多特异性抗体 | |
| CA2756244A1 (en) | Multispecific antibodies comprising full length antibodies and single chain fab fragments | |
| RU2007129676A (ru) | Антитела к рецептору альфа 1 il-13 и их применение | |
| JP2017537896A5 (enExample) | ||
| JP2020515277A5 (enExample) | ||
| RU2019134462A (ru) | Антитела, связывающиеся с steap-1 | |
| JP7657591B2 (ja) | 二重特異性抗原結合コンストラクト | |
| AU2021224200A1 (en) | Engineered anti-HER2 bispecific proteins | |
| JPWO2021064137A5 (enExample) | ||
| JP2022028645A5 (enExample) | ||
| JPWO2023056252A5 (enExample) | ||
| JPWO2021148006A5 (enExample) | ||
| RU2023135060A (ru) | Антитела, связывающиеся с cd3 | |
| JPWO2023045977A5 (enExample) | ||
| JPWO2021089513A5 (enExample) | ||
| RU2019122411A (ru) | Анти сd3 антитело и молекула, содержащая это антитело | |
| JPWO2023089587A5 (enExample) |